Ridgeback Biotherapeutics
Get Full AccessDescription
- Ridgeback Biotherapeutics is a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases. The team at Ridgeback is dedicated to working toward finding life-saving and life changing solutions for patients and diseases that need champions. Headquartered in Miami, Florida, Ridgeback Biotherapeutics is a privately held, majority woman-owned biotechnology company; all funding for Ridgeback Biotherapeutics has originated from Wayne and Wendy Holman; two science driven individuals who invest in technologies that they believe will make the world a better place.
-
Headquarters:3480 Main Highway Unit 402, Miami, Florida, United States
More -
Phone Number:
-
Website: https://www.ridgebackbio.com/
-
Employees:9
-
Revenue:$10 - 50M
-
Legal Name:Ridgeback Biotherapeutics
-
Ridgeback Biotherapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 923120 |
Show More
Frequently Asked Questions regarding Ridgeback Biotherapeutics
-
Where are Ridgeback Biotherapeutics's Headquarters?
Ridgeback Biotherapeutics's Headquarters are in 3480 Main Highway Unit 402,Miami,Florida,United States
-
What is Ridgeback Biotherapeutics's official website?
Ridgeback Biotherapeutics's official website is https://www.ridgebackbio.com/
-
What is Ridgeback Biotherapeutics's Revenue?
Ridgeback Biotherapeutics's revenue is $10 - 50M
-
What is Ridgeback Biotherapeutics's NAICS code?
Ridgeback Biotherapeutics's NAICS code is 923120
-
How many employees are working in Ridgeback Biotherapeutics
Ridgeback Biotherapeutics has 9 employees
-
What is Ridgeback Biotherapeutics's Industry?
Ridgeback Biotherapeutics is in the industry of Biotechnology
-
Who is Ridgeback Biotherapeutics's CEO?
Ridgeback Biotherapeutics's CEO is Wendy Holman
-
Who is Ridgeback Biotherapeutics's Chief Operating Officer?
Ridgeback Biotherapeutics's Chief Operating Officer is Lisa Cozza

